logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Tencent Cloud launches Intelligent Body Development Platform 3.0 globally.

date
17/09/2025
On September 17, 2025, at the Tencent Global Digital Ecosystem Conference, Tencent Cloud announced that the Intelligent Body Development Platform 3.0 has been launched globally, and the key intelligent body technology of Tencent YouTu Lab will continue to be open source.
Latest
2 m ago
LYFT's stock price rose 15% in pre-market trading.
2 m ago
LYFT's stock price rose 15% in pre-market trading.
3 m ago
Huachuang Cloud Message: Huachuang Securities is actively promoting efforts to drive the qualification of Pacific Securities shareholders.
3 m ago
Before the opening of the U.S. stock market on Wednesday, Johnson & Johnson's stock price slightly increased, following reports that the company's experimental psoriasis drug showed potential superiority over the treatment from AbbVie's Humira.
3 m ago
Before the market opens on Wednesday, the stock price of Johnson & Johnson has slightly increased. Earlier reports indicated that the company's experimental psoriasis drug showed potential superiority over the treatment of Pfizer's Stelara.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.